Granules India gets USFDA nod for overactive bladder treatment capsule

"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc, a wholly owned foreign subsidiary of Granules India Ltd, for Trospium Chloride extended-release capsules, 60 mg," the company said in a regulatory filing.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news